EVERSANA is a global commercialization partnership platform for life science products. Our integrated approach is rooted in the patient experience and spans all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
EVERSANA will be at BIO 2022 and would love to meet with you to discuss:
- CO-FINANCING COMMERCIALIZATION PARTNERSHIPS
EVERSANA™ COMPLETE Commercialization is helping manufacturers seeking to launch their own product while limiting the cost of building infrastructure, reducing risk, maintaining full ownership and capturing full revenue potential through maturity. We have signed 15 EVERSANA COMPLETE partnerships in last 2 years.
- IN-LICENSING PARTNERSHIPS TO SOLVE FOR COMMERCIAL CAPACITY AND CAPABILITY CONSTRAINTS
Partnering with EVERSANA enables companies to increase the number of assets they can in-license and commercialize which will accelerate growth rates and support increased valuations. The EVERSANA platform can commercialize any therapeutic modality for any major market in the world. - COMMERCIALIZATION ACROSS GLOBAL MARKETS
We are constantly evolving and adapting to solve the complex challenges our clients are facing in local and global markets. Speak with experts from our Canadian and APAC teams at BIO 2022.
Meet us at BIO 2022 to learn more or schedule a time to meet our experts.
